bioMérieux obtient l'autorisation 510(k) de la FDA américaine pour son système d'antibiogramme VITEK® REVEAL™

21 Jun 2024 08:35 CEST

Subscribe
Issuer

BIOMERIEUX

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1264451_CP_bioMerieux_VITEK_REVEAL_FDA_autorisation_20240621.pdf

Source

BIOMERIEUX

Provider

Les Echos

Company Name

BIOMERIEUX

ISIN

FR0013280286

Symbol

BIM

Market

Euronext

Attachments

  • Original Link
  • Permalink

Disclaimer

BioMérieux SA published this content on 21 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 June 2024 06:42:02 UTC.